We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
+10.98%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$21.7B
AUM Growth
+$1.52B
Cap. Flow
-$396M
Cap. Flow %
-1.83%
Top 10 Hldgs %
30.74%
Holding
733
New
39
Increased
433
Reduced
235
Closed
15

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$84.2M
2
SYT
Syngenta Ag
SYT
+$72.8M
3
NOV icon
NOV
NOV
+$66.8M
4
DE icon
Deere & Co
DE
+$66.6M
5
POT
Potash Corp Of Saskatchewan
POT
+$66.4M

Sector Composition

Rank Sector Weight
1 Materials 45.09%
2 Energy 26.66%
3 Healthcare 4.74%
4 Industrials 3.46%
5 Consumer Staples 2.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MXIM
226
DELISTED
Maxim Integrated Products
MXIM
$6.42M 0.03%
189,966
-156
-0.1% -$5.2K
IWN icon
227
iShares Russell 2000 Value ETF
IWN
$14.4B
$6.39M 0.03%
61,887
+58,639
+1,805% +$5.83M
DUK icon
228
Duke Energy
DUK
$102B
$6.37M 0.03%
85,875
+1,954
+2% +$141K
UTX.PRA
229
DELISTED
UNITED TECHNOLOGIES CORP CORP UNIT (DE)
UTX.PRA
$6.32M 0.03%
96,894
+5,613
+6% +$370K
NEE icon
230
NextEra Energy
NEE
$187B
$6.3M 0.03%
245,964
+21,792
+10% +$530K
CPHD
231
DELISTED
Cepheid Inc
CPHD
$6.29M 0.03%
131,259
-19,546
-13% -$887K
BIDU icon
232
Baidu
BIDU
$35.8B
$6.04M 0.03%
32,346
+1,300
+4% +$213K
VTRS icon
233
Viatris
VTRS
$20.1B
$5.97M 0.03%
115,819
-15,509
-12% -$762K
SXC icon
234
SunCoke Energy
SXC
$757M
$5.81M 0.03%
270,401
+30,529
+13% +$641K
ARCC icon
235
Ares Capital
ARCC
$13.5B
$5.81M 0.03%
325,353
+27,755
+9% +$477K
NRP icon
236
Natural Resource Partners
NRP
$1.3B
$5.79M 0.03%
34,935
+8,296
+31% +$1.29M
CIM
237
Chimera Investment
CIM
$1.05B
$5.73M 0.03%
119,769
+23,020
+24% +$1.08M
SO icon
238
Southern Company
SO
$110B
$5.51M 0.03%
121,421
+8,881
+8% +$393K
XOM icon
239
ExxonMobil
XOM
$651B
$5.51M 0.03%
54,686
-2,855
-5% -$288K
MRVL icon
240
Marvell Technology
MRVL
$174B
$5.5M 0.03%
383,903
+11,492
+3% +$177K
FRX
241
DELISTED
FOREST LABORATORIES INC
FRX
$5.45M 0.03%
55,009
-7,294
-12% -$680K
CLNY
242
DELISTED
Colony Capital, Inc.
CLNY
$5.34M 0.02%
229,886
+40,789
+22% +$896K
LNN icon
243
Lindsay Corp
LNN
$1.16B
$5.3M 0.02%
62,715
-7,545
-11% -$653K
MFA
244
MFA Financial
MFA
$929M
$5.28M 0.02%
160,736
+28,517
+22% +$922K
HTHT icon
245
Huazhu Hotels Group
HTHT
$12.4B
$5.24M 0.02%
835,200
+225,200
+37% +$1.33M
MLCO icon
246
Melco Resorts & Entertainment
MLCO
$2.1B
$5.17M 0.02%
144,870
-28,393
-16% -$981K
PKX icon
247
POSCO
PKX
$15.8B
$5.14M 0.02%
69,106
-14,008
-17% -$1.02M
MYGN icon
248
Myriad Genetics
MYGN
$530M
$5.06M 0.02%
130,025
-37,857
-23% -$1.41M
NUE icon
249
Nucor
NUE
$56.4B
$4.95M 0.02%
100,513
-2,408
-2% -$124K
MT icon
250
ArcelorMittal
MT
$50.4B
$4.93M 0.02%
144,323
-29,255
-17% -$1.05M

Similar funds

VanEck Associates's Q2 2014 Portfolio in Review

As of Q2 2014, VanEck Associates held 733 positions worth $21.7B, up 7.6% from $20.1B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

VanEck Associates's Q2 2014 filing shows 39 new, 433 increased, 235 reduced and 15 closed positions. Its largest new stake was MAG Silver: 5,536,686 shares worth $52.4M. The largest sale was Monsanto Co, an estimated $84.2M.

By sector, the portfolio is most concentrated in Materials at 45% of assets, up from 45% a quarter earlier, followed by Energy and Healthcare.

  • VanEck Associates's largest Q2 2014 buy was MAG Silver: 5,536,686 shares worth $52.4M.
  • VanEck Associates added most to Yamana Gold, Inc. in Q2 2014, an estimated $110M increase.
  • VanEck Associates's biggest Q2 2014 reduction was Monsanto Co, cutting an estimated $84.2M.
  • VanEck Associates fully exited Weatherford International plc in Q2 2014, selling an estimated $45.6M.
  • VanEck Associates's ten largest holdings make up 31% of its $21.7B portfolio in Q2 2014.
  • VanEck Associates opened 39 new positions and closed 15 in Q2 2014.
  • VanEck Associates's portfolio value rose 7.6% quarter-over-quarter to $21.7B.

Based on VanEck Associates's 13F filing for Q2 2014, filed 14 Aug 2014.